Scuttlebutt
Subscribe
Sign in
Home
Notes
Chat
📰 Editions
🧭 Topics
🎙️ Sources
🗣️ People
📈 Investments
💡 Themes
Archive
About
Novartis - $NVS
CoreWeave's Intrator makes his data-center case as CNBC frets over a 10% AI-doom estimate
8 takeaways: Meta's new electricity pledge, OpenAI's 88-hour math proof, a Novartis CEO's defense of Anthropic's board, and why Cramer wants the odds…
Sep 11
•
Scuttlebutt
Vas Narasimhan: Novartis is holding its growth guidance after three drug setbacks
5 takeaways: Why a $12B deal still "make great financial sense" with one of its three drugs failed, the industry's real phase 3 win rate, and why he…
Sep 11
•
Scuttlebutt
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts